207 related articles for article (PubMed ID: 24146911)
1. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas.
Wang C; Funk CC; Eddy JA; Price ND
PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
Narsia N; Ramagiri P; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
[TBL] [Abstract][Full Text] [Related]
4. A systemic insight into astrocytoma biology across different grades.
Chakraborty S; Ghosh Z
J Cell Physiol; 2019 Apr; 234(4):4243-4255. PubMed ID: 30146735
[TBL] [Abstract][Full Text] [Related]
5. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas.
Li D; Chen P; Li XY; Zhang LY; Xiong W; Zhou M; Xiao L; Zeng F; Li XL; Wu MH; Li GY
OMICS; 2011 Oct; 15(10):673-82. PubMed ID: 21978395
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
7. Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.
Liu Z; Xie M; Yao Z; Niu Y; Bu Y; Gao C
Mol Neurobiol; 2013 Feb; 47(1):325-36. PubMed ID: 23135747
[TBL] [Abstract][Full Text] [Related]
8. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
10. Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.
Polisetty RV; Gautam P; Gupta MK; Sharma R; Gowda H; Renu D; Shivakumar BM; Lakshmikantha A; Mariswamappa K; Ankathi P; Purohit AK; Uppin MS; Sundaram C; Sirdeshmukh R
Sci Rep; 2016 Jun; 6():26882. PubMed ID: 27246909
[TBL] [Abstract][Full Text] [Related]
11. Integrated systems-genetic analyses reveal a network target for delaying glioma progression.
Laaniste L; Srivastava PK; Stylianou J; Syed N; Cases-Cunillera S; Shkura K; Zeng Q; Rackham OJL; Langley SR; Delahaye-Duriez A; O'Neill K; Williams M; Becker A; Roncaroli F; Petretto E; Johnson MR
Ann Clin Transl Neurol; 2019 Sep; 6(9):1616-1638. PubMed ID: 31420939
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
Dreyfuss JM; Johnson MD; Park PJ
Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
[TBL] [Abstract][Full Text] [Related]
13. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
[TBL] [Abstract][Full Text] [Related]
15. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.
Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A
Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812
[TBL] [Abstract][Full Text] [Related]
16. Identification of transcriptional regulatory networks specific to pilocytic astrocytoma.
Deshmukh H; Yu J; Shaik J; MacDonald TJ; Perry A; Payton JE; Gutmann DH; Watson MA; Nagarajan R
BMC Med Genomics; 2011 Jul; 4():57. PubMed ID: 21745356
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
18. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
[TBL] [Abstract][Full Text] [Related]
19. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
20. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.
Marie SK; Okamoto OK; Uno M; Hasegawa AP; Oba-Shinjo SM; Cohen T; Camargo AA; Kosoy A; Carlotti CG; Toledo S; Moreira-Filho CA; Zago MA; Simpson AJ; Caballero OL
Int J Cancer; 2008 Feb; 122(4):807-15. PubMed ID: 17960622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
